MedTrace Logo

Laser Outcomes Associated With (Holmium Laser Enucleation of the Prostate) HoLEP Procedures

NCT06531473 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 278

Last updated 2026-08-20

No results posted yet for this study

Summary

The primary aim is to assess the impact of laser setting frequency and wattage during holmium laser enucleation of the prostate.

Conditions

  • Urologic Diseases
  • Prostate Obstruction

Interventions

PROCEDURE

HoLEP

Patients will be randomized to one of the laser energy groups day of surgery.

Sponsors & Collaborators

Principal Investigators

  • Amy Krambeck, MD · Northwestern University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-04
Primary Completion
2025-08-30
Completion
2026-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06531473 on ClinicalTrials.gov